News

May 20th, 2020

Presentation of “SPI2” Phase III Results at the EAN Virtual Congress 2020
Read more

March 10th, 2020

MedDay Reports Top-Line Data from Phase III Trial “SPI2” for Treatment of Progressive Forms of Multiple Sclerosis
Read more